Company intelligence / Profile preview

Pacific Shuanglin Bio-pharmacy

Ownership: Private
Employees: ~2635
Development stage: Commercial

Overview

Pacific Shuanglin Bio-pharmacy is a leading Chinese biopharma company specializing in the development, manufacturing, and commercialization of blood-derived biologics such as albumin and various therapeutic/immunological proteins for infectious disease prevention/treatment[1][2][6]. The company has a strong domestic market presence with growing international reach[4][5]. Its products are widely used for immune support and infection control.

Therapeutic areas: Infectious Diseases
Modalities: BiologicProteinImmunoglobulin
Industry: Biotech

Drug pipeline

5 assets

human albumin

Commercial

4 more assets in the full pipeline.

Request access →

Partnerships

Xinjiang Deyuan Bioengineering (strategic plasma supply partnership)

Beyond the preview

Go deeper on Pacific Shuanglin Bio-pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pacific Shuanglin Bio-pharmacy.

Explore the full profile